Kosten für den Erwerb ungenutzter Corona-Impfstoff-Dosen

This question asks about the financial costs incurred by the German government for purchasing COVID-19 vaccine doses that were not used. It seeks to understand the financial implications of vaccine procurement and potential waste, affecting public health spending and resource allocation.